Current studies have highlighted that a low or insufficient level of T-cadherin expression in a variety of tumor cells is often closely correlated with the malignant features, as observed in breast cancer, colorectal cancer, endometrial cancer, bladder cancer, melanoma, and squamous cell cancer (45–50). The gene discussed is CDH13; the disease is squamous cell carcinoma.